Legal Medicine
Volume 14, Issue 1 , Pages 51-54, January 2012

Evaluation of latex agglutination tests for fibrin–fibrinogen degradation products in the forensic identification of menstrual blood

  • Tomoko Akutsu

      Affiliations

    • National Research Institute of Police Science, 6-3-1, Kashiwanoha, Kashiwa, Chiba 277-0882, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 4 7135 8001; fax: +81 4 7133 9159.
  • ,
  • Ken Watanabe

      Affiliations

    • National Research Institute of Police Science, 6-3-1, Kashiwanoha, Kashiwa, Chiba 277-0882, Japan
  • ,
  • Hisako Motani

      Affiliations

    • Department of Legal Medicine, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, Chiba 260-8670, Japan
  • ,
  • Hirotaro Iwase

      Affiliations

    • Department of Legal Medicine, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, Chiba 260-8670, Japan
  • ,
  • Koichi Sakurada

      Affiliations

    • National Research Institute of Police Science, 6-3-1, Kashiwanoha, Kashiwa, Chiba 277-0882, Japan

Received 12 October 2011; received in revised form 18 October 2011; accepted 21 October 2011. published online 21 December 2011.

Abstract 

The identification of menstrual blood is important when discriminating menstruation from vaginal trauma in sexual assault cases. The aim of this study was to evaluate two fibrin–fibrinogen degradation product (FDP)-latex agglutination test kits, FDPL® Test (FDP-L) and FDP Plasma “RD” (FDP-P), for their ability to forensically identify menstrual blood. Sensitivity and specificity of the two kits were compared for menstrual blood and various body fluids, and the sensitivity of the FDP-latex agglutination test kit was also compared with that of an immunochromatographic test for human hemoglobin. The robustness of the FDP-latex agglutination test was compared with that of gene expression analysis of menstrual blood specific markers. The FDP-L kit was more sensitive than the FDP-P kit, but it cross-reacted with peripheral bloodstains from healthy volunteers. The FDP-P kit was specific for menstrual blood, with the exception of postmortem blood samples, and was not affected by other body fluids. In an FDP-negative menstrual blood sample, the sensitivity of human hemoglobin detection was lower than for FDP-positive samples and peripheral blood stains, suggesting that determination of human hemoglobin could be useful in interpreting negative results in the FDP-latex agglutination test. In menstrual blood samples incubated in wet conditions, FDP was found to be a robust marker in the identification of menstrual blood compared with mRNA markers. FDP-P testing was shown to be a suitable and highly efficient rapid screening test for the laboratory identification of menstrual blood.

Keywords: Fibrin–fibrinogen degradation product, Latex agglutination test, mRNA, Menstrual blood, Real-time RT-PCR

 

PII: S1344-6223(11)00135-0

doi:10.1016/j.legalmed.2011.10.003

Legal Medicine
Volume 14, Issue 1 , Pages 51-54, January 2012